Should Glass House Brands’ NYSE Debut and Medical Pivot Reshape the GLAS Investment Narrative?

Glass House Brands recently began trading on the New York Stock Exchange under the ticker “GLAS” after reorganizing around its medical cannabis operations and moving its adult-use activities into a wholly owned subsidiary. This shift, coming on the heels of federal rescheduling of medical cannabis to Schedule III, positions the company to pursue opportunities such as interstate commerce and potential exports to Europe. With these changes as a backdrop, we’ll explore how Glass House Brands’...